SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Recent filings
Filed 2026-04-06 14:39
Tx date 2026-04-02 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
+$200,000 vol 		$600,000
Older filings
Filed 2026-03-17 14:58
Tx date 2026-03-13 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
+$200,000 vol 		$400,000
Filed 2026-03-04 20:41
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
+$200,000 vol 		$200,000
Filed 2026-03-04 20:39
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Brooks III, John Lawrence
4 - Director of Issuer
Holder: Brooks Family Office LLC (Control or Direction)
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
+$25,000 vol 		$25,000
Filed 2026-03-04 20:37
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol 		$100,000
Filed 2026-03-04 20:34
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes (US$)
16 - Acquisition or disposition under a prospectus exemption
+$25,000 vol 		$25,000
Filed 2026-03-04 20:29
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$25,000 vol
Filed 2026-03-04 20:28
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol
Filed 2026-03-04 20:27
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$200,000 vol
Filed 2026-03-04 20:24
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Brooks III, John Lawrence
4 - Director of Issuer
Holder: Brooks Family Office LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$25,000 vol
Filed 2026-03-04 15:01
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol
Filed 2026-03-04 15:01
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$100,000 vol 		$100,000
Filed 2026-03-04 15:01
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Convertible Notes
00 - Opening Balance-Initial SEDI Report
Filed 2026-03-04 14:59
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$200,000 vol 		$200,000
Filed 2026-03-04 14:59
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$200,000 vol
Filed 2026-03-04 14:59
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Convertible Notes
00 - Opening Balance-Initial SEDI Report
Filed 2026-03-04 14:58
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Brooks III, John Lawrence
4 - Director of Issuer
Holder: Brooks Family Office LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$25,000 vol
Filed 2026-03-04 14:58
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Brooks III, John Lawrence
4 - Director of Issuer
Holder: Brooks Family Office LLC (Control or Direction)
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$25,000 vol 		$25,000
Filed 2026-03-04 14:57
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Brooks III, John Lawrence
4 - Director of Issuer
Holder: Brooks Family Office LLC (Control or Direction)
Convertible Notes
00 - Opening Balance-Initial SEDI Report
Filed 2026-03-04 14:55
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$25,000 vol
Filed 2026-03-04 14:55
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
+$25,000 vol 		$25,000
Filed 2026-03-04 14:54
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption 		$
+$25 vol
$1,000 each
Filed 2026-03-04 14:53
Tx date 2026-02-27 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption 		$
+$25 vol
$1,000 each
Filed 2026-03-04 14:52
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Notes
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-26 14:22
Tx date 2025-12-17 		$SHRX
Sharp Therapeutics Corp. 		Jonasson, Edward
5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+225,000 vol 		349,500
Filed 2026-01-26 14:12
Tx date 2025-05-21 		$SHRX
Sharp Therapeutics Corp. 		Sugarman, Lorne
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		222,500
Filed 2026-01-22 10:59
Tx date 2025-05-21 		$SHRX
Sharp Therapeutics Corp. 		Brooks III, John Lawrence
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		40,000
Filed 2026-01-22 10:58
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Brooks III, John Lawrence
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-22 10:54
Tx date 2025-05-21 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		40,000
Filed 2026-01-22 10:52
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2026-01-22 10:50
Tx date 2025-05-21 		$SHRX
Sharp Therapeutics Corp. 		Stephan, Dietrich Aziz
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		200,842
Filed 2026-01-22 10:44
Tx date 2025-05-21 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+40,000 vol 		40,000
Filed 2026-01-22 10:38
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
Filed 2025-11-04 17:55
Tx date 2025-11-03 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$245.00
+100 vol
$2.45 each 		25,900
Filed 2025-11-03 10:39
Tx date 2025-10-31 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$7,105
+2,900 vol
$2.45 each 		25,800
Filed 2025-10-30 12:21
Tx date 2025-10-29 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,220
+2,000 vol
$2.61 each 		22,900
Filed 2025-10-28 17:31
Tx date 2025-10-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$3,393
+1,300 vol
$2.61 each 		20,900
Filed 2025-10-27 10:49
Tx date 2025-10-24 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,305
+500 vol
$2.61 each 		19,600
Filed 2025-10-23 13:15
Tx date 2025-10-22 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$9,917
+3,800 vol
$2.61 each 		19,100
Filed 2025-10-23 13:15
Tx date 2025-10-21 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$8,874
+3,400 vol
$2.61 each 		15,300
Filed 2025-10-21 14:51
Tx date 2025-10-20 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$522.00
+200 vol
$2.61 each 		11,900
Filed 2025-10-21 14:51
Tx date 2025-10-20 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$512.00
+200 vol
$2.56 each 		11,700
Filed 2025-10-21 14:50
Tx date 2025-10-17 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$764.97
+300 vol
$2.55 each
Filed 2025-10-21 14:47
Tx date 2025-10-17 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$764.97
+300 vol
$2.55 each
Filed 2025-10-20 11:15
Tx date 2025-10-16 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$633.00
+300 vol
$2.11 each 		9,100
Filed 2025-10-20 11:15
Tx date 2025-10-16 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$420.00
+200 vol
$2.10 each 		8,800
Filed 2025-10-20 11:14
Tx date 2025-10-16 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$6,119
+2,900 vol
$2.11 each 		8,600
Filed 2025-10-20 11:05
Tx date 2025-10-17 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$5,355
+2,100 vol
$2.55 each 		11,500
Filed 2025-10-20 09:01
Tx date 2025-10-17 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$764.97
+300 vol
$2.55 each 		6,000
Filed 2025-10-20 08:59
Tx date 2025-10-16 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$190.00
+100 vol
$1.90 each 		5,700
Filed 2025-10-14 14:28
Tx date 2025-10-10 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$2,400
+1,500 vol
$1.60 each 		5,600
Filed 2025-10-09 14:37
Tx date 2025-10-08 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,400
+1,000 vol
$1.40 each 		4,100
Filed 2025-10-08 14:19
Tx date 2025-10-07 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$572.00
+400 vol
$1.43 each 		3,100
Filed 2025-10-08 14:19
Tx date 2025-10-07 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$143.00
+100 vol
$1.43 each 		2,700
Filed 2025-10-08 14:18
Tx date 2025-10-07 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$104.00
+100 vol
$1.04 each 		2,600
Filed 2025-10-06 15:15
Tx date 2025-10-03 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,236
+2,500 vol
$0.4947 each 		2,500
Filed 2025-10-06 15:14
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2025-09-09 10:26
Tx date 2025-08-25 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$1,050
+500 vol
$2.10 each 		870,747
Filed 2025-09-09 10:09
Tx date 2025-08-26 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$73.22
+100 vol
$0.73 each 		870,847
Filed 2025-05-21 16:21
Tx date 2025-04-22 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Common Shares
54 - Exercise of warrants 		$5,000
+3,431 vol
$1.46 each 		4,774,743
Filed 2025-05-21 16:20
Tx date 2025-04-22 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Warrants
54 - Exercise of warrants
-3,431 vol 		30,876
Filed 2025-05-21 16:17
Tx date 2025-04-22 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Common Shares
54 - Exercise of warrants 		$244,994
+168,104 vol
$1.46 each 		7,506,568
Filed 2025-05-21 16:16
Tx date 2025-04-22 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Warrants
54 - Exercise of warrants
-168,104 vol 		1,512,938
Filed 2025-02-06 14:32
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Stephan, Dietrich Aziz
4 - Director of Issuer
Holder: LifeX Seed LLC (Control or Direction)
Common Shares
37 - Stock split or consolidation
-276,816 vol 		30,758
Filed 2025-02-06 14:30
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Stephan, Dietrich Aziz
4 - Director of Issuer
Holder: Cyto Ventures Fund I, L.P. (Control or Direction)
Common Shares
37 - Stock split or consolidation
-1,897,336 vol 		210,816
Filed 2025-02-06 14:29
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Stephan, Dietrich Aziz
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-1,447,581 vol 		160,842
Filed 2025-02-06 14:26
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-8,345,648 vol 		927,294
Filed 2025-02-06 14:24
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-7,832,223 vol 		870,247
Filed 2025-02-06 14:21
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: William Rankin Newlin III Trust Dated 6/21/2016 (Control or Direction)
Common Shares
37 - Stock split or consolidation
-85,753 vol 		9,529
Filed 2025-02-06 14:20
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Tucker Newlin Garvey Trust Dated 6/21/2016 (Control or Direction)
Common Shares
37 - Stock split or consolidation
-128,629 vol 		14,293
Filed 2025-02-06 14:19
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: TTEES FBO Douglas John Balsley II (Control or Direction)
Common Shares
37 - Stock split or consolidation
-171,506 vol 		19,057
Filed 2025-02-06 14:18
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Warrants
37 - Stock split or consolidation
-308,763 vol 		34,307
Filed 2025-02-06 14:17
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Common Shares
37 - Stock split or consolidation
-42,941,799 vol 		4,771,312
Filed 2025-02-06 14:15
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Maverick Leo Newlin Trust Dated 12/5/17 (Control or Direction)
Common Shares
37 - Stock split or consolidation
-85,753 vol 		9,529
Filed 2025-02-06 14:14
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Madison Newlin Garvey Trust Dated 6/21/2016 (Control or Direction)
Common Shares
37 - Stock split or consolidation
-128,629 vol 		14,293
Filed 2025-02-06 14:13
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Jaspar Rock Newlin Trust Dated 6/21/2016 (Control or Direction)
Common Shares
37 - Stock split or consolidation
-85,753 vol 		9,529
Filed 2025-02-06 13:39
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Warrants
37 - Stock split or consolidation
-15,129,387 vol 		1,681,042
Filed 2025-02-06 13:33
Tx date 2025-01-27 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Common Shares
37 - Stock split or consolidation
-66,046,170 vol 		7,338,464
Filed 2025-01-06 18:19
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Stephan, Dietrich Aziz
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		1,608,423
Filed 2025-01-06 18:19
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Stephan, Dietrich Aziz
4 - Director of Issuer
Holder: Cyto Ventures Fund I, L.P. (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		2,108,152
Filed 2025-01-06 18:18
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Stephan, Dietrich Aziz
4 - Director of Issuer
Holder: LifeX Seed LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		307,574
Filed 2024-12-18 11:28
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report 		343,070
Filed 2024-12-18 11:27
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: William Rankin Newlin III Trust Dated 6/21/2016 (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		95,282
Filed 2024-12-18 11:26
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Tucker Newlin Garvey Trust Dated 6/21/2016 (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		142,922
Filed 2024-12-18 11:25
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: TTEES FBO Douglas John Balsley II (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		190,563
Filed 2024-12-18 11:25
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Newlin Investment Company 1, LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		47,713,111
Filed 2024-12-18 11:24
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Maverick Leo Newlin Trust Dated 12/5/17 (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		95,282
Filed 2024-12-18 11:23
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Madison Newlin Garvey Trust Dated 6/21/2016 (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		142,922
Filed 2024-12-18 11:23
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Newlin, William R.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: Jaspar Rock Newlin Trust Dated 6/21/2016 (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		95,282
Filed 2024-12-18 10:57
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Warrants
00 - Opening Balance-Initial SEDI Report 		16,810,429
Filed 2024-12-18 10:56
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Hathaway, John J.
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: STX Partners, LLC (Control or Direction)
Common Shares
00 - Opening Balance-Initial SEDI Report 		73,384,634
Filed 2024-12-18 10:06
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		9,272,942
Filed 2024-12-18 10:04
Tx date 2024-12-11 		$SHRX
Sharp Therapeutics Corp. 		Sneddon, Scott
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		8,702,470